行情

AVDL

AVDL

Avadel
NASDAQ

实时行情|Nasdaq Last Sale

8.72
-0.34
-3.75%
已收盘, 16:00 03/30 EDT
开盘
8.94
昨收
9.06
最高
9.30
最低
8.40
成交量
41.36万
成交额
--
52周最高
10.75
52周最低
1.030
市值
4.05亿
市盈率(TTM)
-9.8121
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测AVDL价格均价为13.88,最高价位14.00,最低价为13.50。

EPS

AVDL 新闻

更多
  • 沪指高开低走收涨0.11% 中国制造业PMI“意外”重返扩张
  • 新浪财经 · 2小时前
  • 谁给了百度健康独立的勇气?
  • 虎嗅APP · 2小时前
  • 馨月说财经:华尔街正沿着唯一的路线图救市
  • 新浪财经 · 2小时前
  • 摩根士丹利:标普500指数不太可能再探低点
  • 环球外汇网 · 3小时前

所属板块

制药
+4.97%
制药与医学研究
+4.75%

热门股票

代码
价格
涨跌幅

AVDL 简况

Avadel Pharmaceuticals, PLC is a specialty pharmaceutical company. The Company offers various drug delivery platforms, including Micropump, LiquiTime, Trigger Lock and Medusa. The Company offers its products in various categories, including hospital, including Bloxiverz, Vazculep and Akovaz, and pediatrics, including Karbinal ER, Cefaclor for Oral Suspension, AcipHex Sprinkle and Flexichamber. Bloxiverz is a drug used intravenously in the operating room for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery. Vazculep is used to treat clinically hypotension resulting primarily from vasodilation in the setting of anesthesia. Akovaz is indicated to treat clinically hypotension in the setting of anesthesia. Cefaclor is indicated for the treatment of otitis media, lower respiratory infections, pharyngitis and tonsillitis, urinary tract infections, and skin and skin structure infections, caused by susceptible organisms.
展开

微牛提供Avadel Pharmaceuticals PLC (ADR)(NASDAQ-AVDL)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的AVDL股票新闻,以帮助您做出投资决策。